Maynard Um
-
-
-
-
-
-
-
Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
-
-
-
-
-
-
-
Inhibrx Inc. (INBX) Cancer Drug Draws Interest From Merck & Co, Others - Reuters
-
-
-
-
-
-
-
Inhibrx Biosciences' (INBX) Ozekibart, INBRX-106 are Lined-up For 2026 - Citizens
-
-
-
-
-
-
-
Inhibrx Inc. (INBX) announces CSO change and appoints new President
-
-
-
-
-
-
466,314 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


